Reversal of human cellular senescence: roles of the p53 and p16 pathways
Open accessThe DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Abstract
Telomere erosion and subsequent dysfunction limits the proliferation of normal human cells by a process termed replicative senescence. Replicative senescence is thought to suppress tumorigenesis by establishing an essentially irreversible growth arrest that requires activities of the p53 and pRB tumor suppressor proteins. We show that, depending on expression of the pRB regulator p16, replicative senescence is not necessarily irreversible. We used lentiviruses to express specific viral and cellular proteins in senescent human fibroblasts and mammary epithelial cells. Expression of telomerase did not reverse the senescence arrest. However, cells with low levels of p16 at senescence resumed robust growth upon p53 inactivation, and limited growth upon expression of oncogenic RAS. In contrast, cells with high levels of p16 at senescence failed to proliferate upon p53 inactivation or RAS expression, although they re-entered the cell cycle without growth after pRB inactivation. Our results indicate that the senescence response to telomere dysfunction is reversible and is maintained primarily by p53. However, p16 provides a dominant second barrier to the unlimited growth of human cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“p16, an inhibitor of CDK4 and CDK6, is also key in several types of senescence26; p21 is activated early on senescence entry and p16 is activated later, probably to maintain the senescence phenotype27”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, cells that express low p16 INK4a levels (e.g., SEN(REP) or SEN(XRA) HCA2) senesce in response to severe damage by activating the p53 pathway; when p53 is subsequently inactivated in these cells, they resume proliferation [ 62 ], but do not lose the SASP.”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This accumulation results in persistent activation of RB family proteins, inhibition of E2F transactivation, and consequent cell-cycle arrest, which, in time, cannot be reversed by subsequent inactivation of RB family proteins or p53 (Beause ´ jour et al., 2003).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Beausejour et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In senescent cells, however, the CDK2 inhibitor p21 WAF1/Cip1 ( CDKN1A ) and CDK4/6 inhibitor p16 INK4A ( CDKN2A ) accumulate.”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Beausejour et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cell cycle controlling proteins p16, p21, and p53, normally inhibit cell cycle progression and have been shown to be accumulated in senescent cells [49–51].”
From T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment (2013) · cites this paper as [51]
Experimental — accuracy not yet measured
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Self-citationExtension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
A Third-Generation Lentivirus Vector with a Conditional Packaging System
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., & Naldini, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8463-8471.1998 · Cited by 3,341
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
Self-citationSwitching and Signaling at the Telomere
Blackburn, E. H. (2001) · Cell · doi:10.1016/s0092-8674(01)00492-5 · Cited by 2,107
Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells
Paddison, P. J., Caudy, A. A., Bernstein, E., Hannon, G. J., & Conklin, D. S. (2002) · Genes & Development · doi:10.1101/gad.981002 · Cited by 1,552
Cited by
Items 901–1,000 of 1,003
Chatterjee, D., & Chakrabarti, O. (2021) · International Journal of Cancer · doi:10.1002/ijc.33787 · Cited by 13
Adult progenitor rejuvenation with embryonic factors
Wang, P., Liu, X., Chen, Y., Jun‐Hao, E. T., Yao, Z., Min‐Wen, J. C., Chua, B. Y.-J., Ma, S., Ma, W., Luo, L., et al. (2023) · Cell Proliferation · doi:10.1111/cpr.13459 · Cited by 13
Bramwell, L. R., & Harries, L. W. (2023) · GeroScience · doi:10.1007/s11357-023-00933-z · Cited by 14
Sarangi, U., Paithankar, K. R., Kumar, J. U., Subramaniam, V., & Sreedhar, A. S. (2012) · Drug Target Insights · doi:10.4137/dti.s9943 · Cited by 16
A Neuroregenerative Human Ensheathing Glia Cell Line with Conditional Rapid Growth
García‐Escudero, V., Gargini, R., Gallego-Hernández, M. T., García-Gómez, A., Martín‐Bermejo, M. J., Simón, D., Delicado, A., Moreno-Flores, M. T., Ávila, J., & Lim, F. (2011) · Cell Transplantation · doi:10.3727/096368910x522108 · Cited by 13
Necdin, a p53-Target Gene, Is an Inhibitor of p53-Mediated Growth Arrest
Lafontaine, J., Rodier, F., Ouellet, V., & Mes‐Masson, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031916 · Cited by 16
Oncogene-mediated tumor transformation sensitizes cells to autophagy induction
Gargini, R., García‐Escudero, V., Izquierdo, M., & Wandosell, F. G. (2016) · Oncology Reports · doi:10.3892/or.2016.4699 · Cited by 16
LncRNA RP11‐670E13.6 Regulates Cell Cycle Progression in UVB Damaged Human Dermal Fibroblasts
Li, M., Li, L., Zhang, X., Yan, Y., & Wang, B. (2018) · Photochemistry and Photobiology · doi:10.1111/php.12858 · Cited by 13
Yuan, J., Zhang, F., Hallahan, D. E., Zhang, Z., He, L., Wu, L., You, M., & Yang, Q. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0857-5 · Cited by 14
RetractedSenescent Astrocytes: A New Player in Brain Aging and Cognitive Decline
Pessoa, B., Hayashide, L. D. S., Dias, G. R., Pontes, B., Pinto, R. S., & Diniz, L. P. (2026) · Brain Sciences · doi:10.3390/brainsci16010076 · Cited by 14
Lee, A.-Y., Jang, K.-H., & Jo, C. H. (2022) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-022-00440-w · Cited by 15
Heterogeneity of ILC2s in the Lungs
Asaoka, M., Kabata, H., & Fukunaga, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.918458 · Cited by 15
Translation of Cellular Senescence to Novel Therapeutics: Insights From Alternative Tools and Models
Inci, N., Kamali, D., Akyildiz, E. O., Tahir Turanli, E., & Bozaykut, P. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.828058 · Cited by 13
Yuniartha, R., Arfian, N., Setyaningsih, W. A. W., Kencana, S. M. S., & Sari, D. C. R. (2022) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2022.29.6.5 · Cited by 15
Skeletal Senescence with Aging and Type 2 Diabetes
Farr, J. N. (2023) · Endocrinology and Metabolism · doi:10.3803/enm.2023.1727 · Cited by 14
Inhibitor PF-04691502 works as a senolytic to regulate cellular senescence
Fan, Z., Tong, Y., Yang, Z., Wang, S., Huang, T., Yang, D., Ni, Q., Zhang, M., Li, D., Yang, M., et al. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112359 · Cited by 14
Jacob, J., Aggarwal, A., Bhattacharyya, S., Sahni, D., Sharma, V., & Aggarwal, A. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177573 · Cited by 16
Increased chromatin accessibility underpins senescence
Lopes‐Paciencia, S., & Ferbeyre, G. (2025) · FEBS Journal · doi:10.1111/febs.70136 · Cited by 18
HPV-ISH-Negative Invasive Cervical Squamous Cell Carcinoma: Histologic and Pap Test Results
Alexander, C. J., White, M. J., Maleki, Z., & Rodriguez, E. F. (2019) · Acta Cytologica · doi:10.1159/000500595 · Cited by 13
Janik, K., Tręda, C., Włodarczyk, A., Peciak, J., Rosiak, K., Zięba, J., Grot, D., Rutkowska, A., Pawłowska, R., Och, W., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-6130-2 · Cited by 12
Role of mismatch repair in aging
Wen, J., Wang, Y., Yuan, M., Huang, Z., Zou, Q., Pu, Y., Zhao, B., & Cai, Z. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.64953 · Cited by 16
Broniarczyk, J. K., Ring, N., Massimi, P., Giacca, M., & Banks, L. (2018) · Scientific Reports · doi:10.1038/s41598-017-18809-6 · Cited by 12
Tang, H., Xu, L., Liang, X., & Gao, G. (2018) · Oncology Letters · doi:10.3892/ol.2018.9474 · Cited by 13
α-Mangostin induces G1 cell cycle arrest in HCT116 cells through p38MAPK-p16INK4a pathway
Korm, S., Jeong, H., Kwon, O., Park, J., Cho, H., Kim, Y., Chin, Y., & Cha, H. (2015) · RSC Advances · doi:10.1039/c5ra00780a · Cited by 15
Honoki, K., & Tsujiuchi, T. (2013) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2013.820010 · Cited by 13
Vilgelm, A. E., & Richmond, A. J. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1009299 · Cited by 12
N‑cadherin attenuates nucleus pulposus cell senescence under high‑magnitude compression
Niu, M., Ma, F., Qian, J., Li, J., Wang, T., Gao, Y., & Jin, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8239 · Cited by 14
Pan, Y., Xu, H., Liu, R., & Jia, L. (2012) · Europe PMC (PubMed Central) · Cited by 16
Mechanisms and therapeutic strategies linking mesenchymal stem cells senescence to osteoporosis
Tong, Y., Tu, Y., Wang, J., Liu, X., Su, Q., Wang, Y., & Wang, W. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1625806 · Cited by 19
IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy
Romaniello, D., Gelfo, V., Pagano, F., Sgarzi, M., Morselli, A., Girone, C., Filippini, D. M., D’Uva, G., & Lauriola, M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1083743 · Cited by 15
Immortalized cell lines derived from dental/odontogenic tissue
Zeng, Y., Liu, L., Huang, D., & Song, D. (2023) · Cell and Tissue Research · doi:10.1007/s00441-023-03767-5 · Cited by 12
Su, Y., Xiao, L., Huang, S.-Y., Wu, C., Chang, L.-C., Chen, Y., Luo, H., Huang, C., Liu, T., & Peng, J. (2023) · Cells · doi:10.3390/cells12111471 · Cited by 13
Agarwal, H., Tal, P., Goldfinger, N., Chattopadhyay, E., Malkin, D. M., Rotter, V., & Attery, A. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01307-4 · Cited by 10
Okudaira, N., Akimoto, M., Susa, T., Akimoto, M., Hisaki, H., Iizuka, M., Okinaga, H., Almunia, J. A., Ogiso, N., Okazaki, T., et al. (2024) · Aging Cell · doi:10.1111/acel.14206 · Cited by 12
mTOR Signaling in Melanoma: Oncogene-Induced Pseudo-Senescence?
Souroullas, G. P., & Sharpless, N. E. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.12.005 · Cited by 15
Jeyapalan, J. C., & Sedivy, J. M. (2013) · Aging · doi:10.18632/aging.100536 · Cited by 11
The paracrine effects of fibroblasts on Doxorubicin-treated breast cancer cells
Fourie, C., Davis, T., Kriel, J., & Engelbrecht, A. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.05.020 · Cited by 13
Setel, D. D., Beker, M., Uşak, Ş. T., & Elibol, B. (2021) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2021.104584 · Cited by 11
Mechanisms of Senescence in Cancer: Positive and Negative Aspects of Cancer Cells Senescence
Zaczek, A., Kalenik, S., & Rodacka, A. (2023) · Cellular Physiology and Biochemistry · doi:10.33594/000000671 · Cited by 12
Continued Stabilization of the Nuclear Higher-Order Structure of Post-Mitotic Neurons In Vivo
Alva-Medina, J., Maya‐Mendoza, A., Dent, M. A. R., & Aranda‐Anzaldo, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021360 · Cited by 12
To senesce or not to senesce: how primary human fibroblasts decide their cell fate after DNA damage
Kollárovič, G., Studencka‐Turski, M., Ivanova, L., Lauenstein, C., Heinze, K., Lapytsko, A., Talemi, S. R., Figueiredo, A. S., & Schaber, J. (2016) · Aging · doi:10.18632/aging.100883 · Cited by 12
Chan, K. T., Paavolainen, L., Hannan, K. M., George, A. J., Hannan, R. D., Simpson, K. J., Horváth, P., & Pearson, R. B. (2016) · Assay and Drug Development Technologies · doi:10.1089/adt.2016.739 · Cited by 11
Retracted: Effects and mechanism of puerarin on the human retinoblastoma cells
Yang, C., Fan, X., & Fan, S. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26565 · Cited by 12
RetractedThe ING1a model of rapid cell senescence
Bertschmann, J., Thalappilly, S., & Riabowol, K. T. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.06.004 · Cited by 14
Voic, H., Li, X., Jang, J.-H., Zou, C., Sundd, P., Alder, J. K., Rojas, M. M., Chandra, D., Randell, S. H., Mallampalli, R. K., et al. (2019) · BMC Genomics · doi:10.1186/s12864-018-5409-z · Cited by 12
Seo, S. B., Baek, J.-Y., Lim, J., Jin, X., Lee, M., & Lee, J. H. (2019) · Cell Proliferation · doi:10.1111/cpr.12654 · Cited by 12
New Insights into Chronological Mobility of Retrotransposons In Vivo
Ghanam, A. R., Cao, J., Ouyang, X., & Song, X. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2818415 · Cited by 10
Senescent Cultures of Human Dermal Fibroblasts Modified Phenotype When Immobilized in Fibrin Polymer
Acevedo, C., Brown, D. I., Young, M. E., & Reyes, J. G. (2009) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856208x394418 · Cited by 12
Telomeric 8-Oxoguanine Drives Rapid Premature Senescence In The Absence Of Telomere Shortening
Barnes, R. P., de Rosa, M., Thosar, S. A., Detwiler, A. C., Roginskaya, V., Van Houten, B., Bruchez, M. P., Stewart-Ornstein, J., & Opresko, P. L. (2021) · doi:10.1101/2021.05.05.442662
G1/S arrest: a key mechanism of cellular aging and replicative senescence
李向东, Yan, X., Chen, Q., & Mai, S. (2026) · Biogerontology · doi:10.1007/s10522-025-10378-w · Cited by 14
Cellular senescence in cancer: Friend or fraud?
Chen, Q., Liu, J., Wu, J., Xiang, X., Zhou, X., Mi, J., Wei, J., Zou, X., & Wu, A. (2026) · Drug Resistance Updates · doi:10.1016/j.drup.2026.101363 · Cited by 20
Novais, E. J., Ottone, O. K., Jagannath, S., Akande, E. J., Barve, R. A., & Risbud, M. V. (2026) · Bone Research · doi:10.1038/s41413-026-00526-4 · Cited by 13
Kang, T., Moore, E. C., Kopania, E. E. K., King, C. D., Schilling, B., Campisi, J., Good, J. M., & Brem, R. B. (2023) · G3: Genes, Genomes, Genetics · doi:10.1093/g3journal/jkad091 · Cited by 10
“reattain activity could be of particular interest as a potential mediator of the return to proliferation 563 seen among senescent cells in certain scenarios (88,89).”
BackgroundSelf-citationde Celis, M. F. R., & Bonner‐Weir, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1217729 · Cited by 13
Systematic transcriptomic analysis and temporal modelling of human fibroblast senescence
Scanlan, R.-L., Pease, L., O’Keefe, H., Guimera, A. M., Rasmussen, L. J., Wordsworth, J., & Shanley, D. P. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1448543 · Cited by 11
The Hippo Signaling Pathway Manipulates Cellular Senescence
Miyajima, C., Nagasaka, M., Aoki, H., Toriuchi, K., Yamanaka, S., Hashiguchi, S., Morishita, D., Aoyama, M., Hayashi, H., & Inoue, Y. (2024) · Cells · doi:10.3390/cells14010013 · Cited by 11
Li, H., Li, G., Gao, X., Chen, C., Cui, Z., Cao, X., & Su, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-95551-4 · Cited by 12
Nanomaterials intervene in cell senescence to reinforce cancer therapy
Sun, S., Yang, N., Nie, J., Yang, Z., Pei, Z., Ding, R., & Cheng, L. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217012 · Cited by 10
Ahmed, S., Gozal, D., & Khalyfa, A. (2025) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2025.102170 · Cited by 12
Yoshizaki, K., Fujiki, T., Tsunematsu, T., Yamashita, M., Udono, M., Shirahata, S., & Katakura, Y. (2009) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.80517 · Cited by 12
Cervical, Ovarian and Endometrial Tumor Markers: Potential Clinical Value
Malhone, C., & Longatto‐Filho, A. (2019) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2019.03.003 · Cited by 11
Targeted Therapeutics Delivery by Exploiting Biophysical Properties of Senescent Cells
Low, J., Chan, B., & Tay, A. K. P. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202107990 · Cited by 11
Cellular Senescence in Adrenocortical Biology and Its Disorders
Gao, X., Li, F., Liu, B., Wang, Y.-X., Wang, Y., & Zhou, H. (2021) · Cells · doi:10.3390/cells10123474 · Cited by 14
The role of p53/p21/p16 in DNA damage signaling and DNA repair
Kulaberoglu, Y., Hergovich, A., & Gómez, V. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85679-9.00015-5 · Cited by 18
Non‐pituitary growth hormone enables colon cell senescence evasion
Chesnokova, V., Zonis, S., Apaydın, T., Barrett, R. J., & Melmed, S. K. (2024) · Aging Cell · doi:10.1111/acel.14193 · Cited by 10
Telomerase: from Aging to Human Cancers
Parsa, N. (2012) · Springer eBooks · doi:10.1007/978-94-007-4632-9_1 · Cited by 17
Moon, S. C., Park, S. C., Yeo, E. J., & Kwak, C. S. (2009) · Journal of Medicinal Food · doi:10.1089/jmf.2008.1111 · Cited by 10
Lafontaine, J., Tchakarska, G., Rodier, F., & Mes‐Masson, A. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-234 · Cited by 10
Senescence and Senescence-Related Disorders
Wang, Z. P., & Inuzuka, H. (2013) · InTech eBooks · doi:10.5772/56158 · Cited by 12
Tracing the path of cancer initiation: the AA protein-based model for cancer genesis
Adjiri, A. (2018) · BMC Cancer · doi:10.1186/s12885-018-4739-1 · Cited by 13
He, Z., Li, Y., Lian, Z., Liu, J., Xian, H., Jiang, R., Hu, Z., Fang, D., & Hu, D. (2020) · Journal of Applied Toxicology · doi:10.1002/jat.4043 · Cited by 11
Ivanov, M., Titov, S. E., Dzyubenko, V. V., Glushkov, S. A., Krasilnikov, S. E., Mansurova, A. S., Malek, A. V., Берлев, И. В., Prisyazhnaya, T., Kuleshova, S. V., et al. (2021) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2021.01.016 · Cited by 10
Cotarelo, C., Schad, A., Schmidt, M., Hönig, A., Sleeman, J. P., & Thaler, S. (2023) · Cancers · doi:10.3390/cancers15061860 · Cited by 10
Cellular Senescence and Tumor Suppression
Adams, P. D., & Sedivy, J. M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1075-2 · Cited by 10
Lindgren, T., Stigbrand, T. I., Råberg, A., Riklund, K., Johansson, L. F., & Eriksson, D. (2014) · International Journal of Radiation Biology · doi:10.3109/09553002.2015.959668 · Cited by 10
Kang, M., Shin, K.-H., Yip, F. K., & Park, N. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.10.002 · Cited by 10
Zalzali, H., Harajly, M., Abdul-Latif, L., El-Chaar, N. N., Dbaibo, G. S., Skapek, S. X., & Saab, R. H. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-28 · Cited by 11
Factors that may influence polymorphous low-grade adenocarcinoma growth
Soares, A. B., Martinez, E. F., Ribeiro, P. F. A., Barreto, I. S., de Aguiar, M. C. F., Furuse, C., Sperandio, M., Montalli, V. Â. M., de Araújo, N. S., & de Araújo, V. C. (2017) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-017-2085-3 · Cited by 10
Knockdown of MBP-1 in Human Foreskin Fibroblasts Induces p53-p21 Dependent Senescence
Ghosh, A. K., Kanda, T., Steele, R., & Ray, R. B. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003384 · Cited by 10
Sharpless, N. E. (2003) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2003.33.pe24 · Cited by 14
Nuclear Factor-κΒ–Mediated Regulation of Telomerase
Wang, J. C., & Bennett, M. R. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.216937 · Cited by 10
Wu, D., Wu, Y., Zhang, M., & Lan, H. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110961 · Cited by 13
Lee, S., Kim, S. Y., Lee, S., Jang, S., Hwang, S., Kwon, Y., Choi, J., & Kwon, O. (2024) · iScience · doi:10.1016/j.isci.2024.109675 · Cited by 11
Sizek, H., Deritei, D., Fleig, K., Harris, M., Regan, P., Glass, K., & Regan, E. R. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102084 · Cited by 11
Body Composition and Senescence: Impact of Polyphenols on Aging-Associated Events
dos Santos, T. W., Pereira, Q. C., Fortunato, I. M., Oliveira, F. D. S., Alvarez, M. C., & Ribeiro, M. L. (2024) · Nutrients · doi:10.3390/nu16213621 · Cited by 11
Park, S. S., Roh, T. H., Tanaka, Y., Kim, Y. H., Park, S. H., Kim, T.-G., Eom, S. Y., Park, T. J., Park, I., Kim, S.-H., et al. (2024) · Neoplasia · doi:10.1016/j.neo.2024.101116 · Cited by 9
Resetting the aging clock through epigenetic reprogramming: Insights from natural products
Liu, X., Feng, J. H., Guo, M., Chen, C., Zhao, T., Sun, X., & Zhang, Y. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108850 · Cited by 10
Navigating the paradox of senescence and chemoresistance in pancreatic cancer
Jeiroshi, A., Deng, J., Xu, Z., Comandatore, A., Xu, G., Glaviano, A., Morelli, L., Garajová, I., & Giovannetti, E. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.06.007 · Cited by 11
Pasitka, L., Cohen, M., Regenbaum, S., Ehrlich, A., Gildor, B., Gold, A., & Nahmias, Y. (2025) · Nature Food · doi:10.1038/s43016-025-01255-3 · Cited by 16
Mastoridou, E. M., GOUSSIA, A. C., Kataki, A., Koniaris, E., Glantzounis, G. K., Papoudou‐Bai, A., Kanavaros, P., & Charchanti, A. V. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27021066 · Cited by 11
Bogdanowicz, P., Roullet, N., Bensadoun, P., Bessou‐Touya, S., Lemaître, J.-M., & Duplan, H. (2023) · International Journal of Cosmetic Science · doi:10.1111/ics.12858 · Cited by 12
Prindull, G. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.07.009 · Cited by 9
Hayat, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-812146-7.00001-9 · Cited by 1
Zhang, G., Dong, K., Liu, J., & Zhou, W. (2022) · Medicine · doi:10.1097/md.0000000000030927 · Cited by 9
Endothelial Senescence in Neurological Diseases
Xiao, X., Jiang, H., Wei, H., Zhou, Y., Ji, X., & Chen, Z. (2023) · Aging and Disease · doi:10.14336/ad.2023.0226-1 · Cited by 9
Weebadda, W. K. C., Jackson, T. J., & Lin, A. W. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20372 · Cited by 9
Bexarotene Induces Cellular Senescence in MMTV-Neu Mouse Model of Mammary Carcinogenesis
Shilkaitis, A. L., Bratescu, L., Green, A., Yamada, T., & Christov, K. T. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0260 · Cited by 9
Holubeková, V., Mendelová, A., Žúbor, P., Kapustová, I., Švecová, I., Kúdela, E., Burjanivová, T., Lasabová, Z., & Danko, J. (2014) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000000 · Cited by 9
Zhang, X., Ji, X., Sun, B., Qian, L., Hu, X.-L., Lou, H., & Yuan, H. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.05.006 · Cited by 9
Csekes, E., Vágvölgyi, M., Hunyadi, A., & Račková, L. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118419 · Cited by 14
Metadata
- Authors
- Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., & Campisi, J.
- Affiliations
- Lawrence Berkeley National Laboratory (US)
- Salk Institute for Biological Studies (US)
- Cold Spring Harbor Laboratory (US)
- Buck Institute for Research on Aging (US)
- Corresponding author
- Campisi, Judith
- Venue
- The EMBO Journal
- Published
- 2003-08-15
- Volume
- 22
- Issue
- 16
- Pages
- 4212-4222
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC175806
- OpenAlex
- W2061619522
- Cited by
- 1,457
- References
- 61
- Citations by year
- 2026: 46 · 2025: 58 · 2024: 87 · 2023: 94 · 2022: 77 · 2021: 107 · 2020: 77 · 2019: 77 · 2018: 78 · 2017: 63 · 2016: 74 · 2015: 55 · 2014: 59 · 2013: 54 · 2012: 69
- FWCI
- 21.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- The EMBO Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- UnissResearch (Università degli Studi di Sassari) (submittedVersion)
- Funders
- Uehara Memorial Foundation
- National Institute on Aging (R56AG009909, R56AG016379, AG-09909, AG-16379, R01AG016379, R37AG009909)
- National Cancer Institute (P30CA008748)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, replicative senescence, p53, p16, retinoblastoma protein, telomere dysfunction, telomerase, oncogenic Ras, growth arrest, senescence reversal, mammary epithelial cells, fibroblasts, tumor suppression
- MeSH terms
- Breast, Cell Line, Epithelial Cells, Fibroblasts, Humans, Luminescent Proteins, Models, Biological, Genes, ras, Signal Transduction, Tumor Suppressor Protein p53, Lentivirus Infections, Cellular Senescence, Telomerase, Cyclin-Dependent Kinase Inhibitor p16, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.